These compounds are reported to have antiinflammatory, hypolipidemic, and cardioprotective effects, indicating their potential use in the treatment of CAD.[45–50] Moreover, quercetin can reduce the transcriptional activity of nuclear factor kappa B (NF-κB), thereby decreasing the levels of inflammatory cytokines such as IL-1β, IL-10, and TNF-α, which may treat CAD via antiinflammatory effects.[51] Resveratrol increases nitric oxide (NO) production in endothelial cells, stimulates endothelial nitric oxide synthase (eNOS) activity, and prevents eNOS uncoupling by upregulating its expression. This evidence concerns the gene IL1B and coronary artery disorder.